BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30701562)

  • 1. Hollow mesoporous silica nanoparticles as delivery vehicle of foot-and-mouth disease virus-like particles induce persistent immune responses in guinea pigs.
    Bai M; Dong H; Su X; Jin Y; Sun S; Zhang Y; Yang Y; Guo H
    J Med Virol; 2019 Jun; 91(6):941-948. PubMed ID: 30701562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
    Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
    Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protective immune response of foot-and-mouth disease vaccine through DNA-loaded virus-like particles.
    Lu Y; Dong H; Li J; Li L; Wang M; Liu H; Teng Z; Zhang Y; Jin Y; Guo H; Yang Y; Wen X; Sun S
    Microb Pathog; 2020 Jun; 143():104130. PubMed ID: 32165331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine.
    Teng Z; Sun S; Chen H; Huang J; Du P; Dong H; Xu X; Mu S; Zhang Z; Guo H
    Vaccine; 2018 Oct; 36(45):6752-6760. PubMed ID: 30268733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.
    Terhuja M; Saravanan P; Tamilselvan RP
    Biologicals; 2015 Nov; 43(6):437-43. PubMed ID: 26493006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
    Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
    Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs.
    Wu P; Zhang Y; Yin X; He Y; Zhang Q; Chen C
    BMC Vet Res; 2020 Dec; 16(1):474. PubMed ID: 33276787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising MS2 mediated virus-like particle vaccine against foot-and-mouth disease.
    Dong YM; Zhang GG; Huang XJ; Chen L; Chen HT
    Antiviral Res; 2015 May; 117():39-43. PubMed ID: 25676866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
    Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
    Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.
    Guo HC; Sun SQ; Jin Y; Yang SL; Wei YQ; Sun DH; Yin SH; Ma JW; Liu ZX; Guo JH; Luo JX; Yin H; Liu XT; Liu DX
    Vet Res; 2013 Jul; 44(1):48. PubMed ID: 23826638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
    J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticulate chitosan-TNF-α-VLPs activate mast cells and enhance adaptive immunity induced by foot-and-mouth disease virus-like particles in mice.
    Bai R; Li M; Tian Z; Hu Y; An M; Yuan W; Li L
    Vet Immunol Immunopathol; 2023 Oct; 264():110662. PubMed ID: 37862872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs.
    Song H; Waheed Abdullah S; Yin S; Dong H; Zhang Y; Tan S; Bai M; Ding Y; Teng Z; Sun S; Guo H
    Vaccine; 2024 Jul; 42(18):3789-3801. PubMed ID: 38714448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
    Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
    Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Hollow Mesoporous Silica Nanoparticles as a Nanocarrier in the Delivery of Foot-And-Mouth Disease Virus-like Particle Vaccines.
    Ru J; Chen Y; Tao S; Du S; Liang C; Teng Z; Gao Y
    ACS Appl Bio Mater; 2024 Feb; 7(2):1064-1072. PubMed ID: 38286026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Protective Immunity against Inactivated Iranian Isolate of Foot-and-Mouth Disease Virus Type O/IRN/2007 Using Gamma Ray-Irradiated Vaccine on BALB/c Mice and Guinea Pigs.
    Motamedi-Sedeh F; Soleimanjahi H; Jalilian AR; Mahravani H; Shafaee K; Sotoodeh M; Taherkarami H; Jairani F
    Intervirology; 2015; 58(3):190-6. PubMed ID: 26202581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Responses to Orally Administered Recombinant
    Zhang F; Zhang Z; Li X; Li J; Lv J; Ma Z; Pan L
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.